Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen

Gane EJ, Shiffman ML, Etzkorn K, et al, et al. Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen. Hepatology. 2017;66(4):1083-1089.

Publication Type:

Journal Article

Authors:

Gane, Edward J.; Shiffman, Mitchell L.; Etzkorn, Kyle; et, al; GS-US-342-1553 Investigators

Source:

Hepatology, Volume 66, Issue 4, p.1083-1089 (2017)

Cited On:

Export Citation:

RIS Format

Top